HIV Malignancy Specimens for Research at No Charge
Our recent experiences with the coronavirus pandemic have demonstrated that new mutations in viral genetic sequences can have significant impacts on the virus’s transmissibility and the degrees of illness it …
How do HIV/AIDS & cancer research continue to converge? Read more about the early results from a novel study which shows that pembrolizumab, a cancer drug, can flush HIV from …
As 2021 comes to a close, we celebrate some important work published by our colleagues (Ambinder, et al) who dedicate their careers to improving diagnosis, treatment and outcomes for people …
The ACSR celebrates Dr. John Mellors, et al, for their recent publication in Science and their groundbreaking research showing the important role of HIV provirus integration in the development of T-Cell Lymphoma …
The early months of the SARS-CoV-2 pandemic forced many laboratories and biobanks, including the ACSR, to develop contingency plans for biobank operations. Fear of the unknown, uncertainty and unpredictability, and …
The ACSR is proud to share the latest EBV/DLBCL research from the ACSR’s own Lisa Rimsza, Alanna Maguire, and inaugural YIPA Awardee, Joo Song! EBV-positive HIV-associated diffuse large B cell …
Everyday, but most especially today, World Cancer Day, the ACSR stands up to cancer. Together, all of our actions matter and the ACSR recommits to supporting our cancer warriors in …
Using ACSR Specimens, Colm Keane et al. give us the largest in-depth description of the biology of Primary Central Nervous Lymphoma occurring in patients with AIDS. This disease demonstrates a …
With support and funding awarded through the ACSR’s Young Investigator Pilot Award, analyses of samples from the ACSR’s African Collections show intriguing new findings that IgE-driven atopic inflammation may contribute …
Using ACSR samples, A. Maguire et al. published their report on “Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature” (Int J Cancer. 2019 …